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Abstract
Objective: Cognitive assessment in individuals with cancer requires both measured performance
on neuropsychological tests and self-report of effectiveness in functioning. Few instruments are
available to assess the perceived impact of cognitive alterations on daily functioning in
individuals treated for cancer. In this study, we investigated the psychometric properties of a
theoretically based instrument, and the Attentional Function Index (AFI), designed to measure
perceived effectiveness in common activities requiring attention and working memory,
particularly the ability to formulate plans, carry out tasks, and function effectively in daily life.
Methods: Women (N5 172), ages 27–86 years, completed the questionnaire before primary
treatment for early stage breast cancer. Construct validity was established using exploratory
principal component factor analysis with varimax rotation.
Results: A 13-item instrument emerged with 3 subscales, namely effective action, attentional
lapses, and interpersonal effectiveness, which explained 74.69% of total variance. The internal
consistency coefficients (Cronbach’s a) were 0.92 for the total instrument, and ranged from 0.80
to 0.92 for the 3 subscales. Further examination of validity indicated that the scores on the AFI
(1) showed expected correlations with established measures of ability to concentrate, cognitive
failures, states of confusion, and mental fatigue, and (2) could distinguish differences in
perceived cognitive functioning between younger and older age groups. AFI scores were not
significantly associated with years of education or presence of comorbid conditions.
Conclusion: The brief AFI has demonstrated usefulness for assessment of perceived cognitive
functioning in populations with life-threatening and chronic illness, such as breast cancer.
Copyright r 2010 John Wiley & Sons, Ltd.
Keywords: cancer; oncology; cognitive function; measurement; instrument
Introduction
Most recent research has focused on assessing
alterations in cognitive function in cancer survivors.
In particular, a growing body of clinical research
has examined the effects of cancer and cancer
therapies on cognitive function [1–3]. To date,
neuropsychological testing has found deficits in a
variety of cognitive domains. Of these, alterations in
basic cognitive functions of attention and working
memory have been consistently reported in persons
having a variety of malignancies and cancer
treatments [1–3]. Presently, there are numerous
established neuropsychological batteries available
for assessment of attention and working memory. In
contrast, few instruments exist that are aimed
specifically at assessing subjective perceptions, or
self-reports, of effectiveness in activities of daily
living, supported by these basic cognitive processes.
Such subjective assessments are needed to better
understand the detrimental effects of these cognitive
problems on key aspects of daily functioning.
The purpose of this report is to describe the
development and testing of an instrument, the
Attentional Function Index (AFI), designed to
assess perceived effectiveness in daily activities
supported by attention and working memory.
The instrument was first developed to assess the
detrimental effects of cognitive or mental fatigue on
daily functioning in women treated for breast
cancer. Since then, other researchers have used
the AFI as a self-report of cognitive functioning in
a variety of populations and conditions, including
healthy individuals and individuals with breast and
lung cancer (Table 1). This paper reviews the
theoretical basis and development of the AFI and
examines its construct validity and reliability. The
ultimate purpose is to make this instrument
available for use by researchers and clinicians.
Theoretical perspective
Selective attention is a basic cognitive capacity
that allows increased sensitivity to important
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environmental stimuli, so that an individual can
efficiently process information and engage in
purposeful behavior [17–19]. According to current
cognitive neuroscience theory, selective attention is
essential for the integrity of higher-order cognitive
and social-affective functions (Smith and Jonides,
1999, for a review [20]). An important form of
selective attention, directed or controlled, is driven
by personal intentions and is characterized by an
ability to actively focus on some information while
ignoring other information in the environment and
to maintain focus on such information for more
than a few seconds at a time [17,18,21]. Directed
attention requires mental effort to actively inhibit
or block distractions that may capture one’s
interest, but are irrelevant to completing an activity
or goal-directed task [17,21]. A close functional
connection between selective attention and work-
ing memory is widely recognized, and both systems
are integral components of effective cognitive
functioning [20,22]. Thus, problems of working
memory are often related to losses in the capacity
to direct attention.
Selective attention provides inhibitory control for
many aspects of cognitive functioning and behavior,
including working memory and higher order cogni-
tive or ‘executive’ functions that are needed for
problem-solving and effective social functioning.
Muriel Lezak first described executive functions as
those cognitive processes that determine how some-
thing gets done or whether it gets done at all [23].
Specifically, the following components of executive
functioning have been identified: (1) establishing
goals; (2) formulating and carrying out plans;
(3) initiating and maintaining an intended activity
so that important goals can be achieved; and
(4) effective interpersonal functioning, including
self-monitoring of behavior, acting at an appro-
priate time (patience and deliberate responses), and
modifying behavior to meet goals [18,23,24].
Research has shown that attention can be
compromised by fatigue, insomnia, and possible
toxic side effects of cancer treatment, such as
chemotherapy, immunotherapy, or brain radiation
[7,25–29]. The hallmark of compromised attention
is increased distraction, experienced as an inability
to concentrate. When attention is compromised
over time, a person experiences a loss of effective-
ness in executive functioning that can lead to a
decreased sense of personal efficacy, irritability,
impulsivity, and mental confusion [4,21].
Few instruments exist that may provide an
insight into the loss of personal effectiveness that
may accompany cognitive dysfunction associated
with life-threatening and chronic illness, such as
cancer. Furthermore, few instruments have been
designed to assess specific functional consequences
of losses in basic cognitive systems of attention and
working memory in a cancer population.
Development of the AFI
The AFI was developed to assess perceptions of
effectiveness in daily life activities that require
directed or controlled attention and the higher
executive processes served by this basic cognitive
system. Face validity and theoretical congruence
was first established by a panel of experts that
included researchers and theorists in cognitive
psychology, neurobehavior, and cognitive neu-
roscience. Content validity of the AFI was origin-
ally examined using nonparametric factor analysis
and a four-factor solution was identified [24]. The
four factors identified were congruent with the
theoretical constructs of directed attention and
executive functions, and included subscales of
effective actions, perceptual effectiveness, lapses in
attention, and interpersonal effectiveness [24]. The
AFI is described below, including items, response
format, time period of assessment, positive/negative






Cimprich [4,5] 32 F Range: 29–84 years (M 5 54 years) Breast cancer 0.89–0.94
Cimprich et al. [6] 184 F Range: 27–86 years (M 5 55 years) Breast cancer 0.91
Cimprich [7] 74 F Range: 25–79 years (M 5 56 years) Breast cancer 0.92
Jansen [8] 54 M and F Range: 65–87 years (M 5 55 years) Community-dwelling elders 0.93
Lee a[9] 125 F Range: 30–69 years (M 5 not reported) Breast cancer/chemotherapy 0.90
Lehto [10] 42 M and F Range: 37–83 years (M 5 64 years) Lung cancer and other lung diseases 0.87–0.92
Lehto and Cimprich [11] 45 F Range: 25–75 years (M 5 55 years) Breast cancer 0.92
Lethbridge et al. [12] 33 M and F Range: not reported (M 5 19 years) Nursing students 0.85
Sanders et al. [13] 32 M and F Range: 23–52 years (M 5 38 years) Nursing students 0.83
Stark [14] 57 F Range: 22–42 years (M 5 29 years) Pregnant women 0.88–0.94
Stark [15] 126 F Range: not reported (M 5 29 years) Pregnant women 0.89–0.99
Tennessen and
Cimprich [16]
72 F Range: 18–25 years (M 5 20 years) University students 0.84
aAFI translated into Korean.
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wording of items, and studies that have used
the AFI.
Items
The AFI was originally designed with 16 items
[4,5,24]. The first 12 items were derived from Lezak’s
4 components of executive functioning, including:
goal formulation, planning, carrying out activities,
and monitoring effective performance. The last four
items of the AFI were formulated to assess
behavioral and affective responses associated with a
lowered capacity to direct attention, including mak-
ing mistakes, forgetting, irritability, and impatience.
Because some individuals may experience discomfort
when responding to items describing attentional
difficulties, those questions were placed at the end
of the instrument to allow for a clearer response [30].
Response format
The visual analogue scale format was chosen to
precisely measure the individual’s perceptions of
how well they are currently functioning. Each of the
items consists of a 100mm horizontal line anchored
with opposite phrases from not at all (0mm) to
extremely well or a great deal (100mm). Subjects are
asked to place a mark on the line that best describes
functioning in relation to the specific activity. Scores
for each item are determined by measuring the
distance from the lower end of the scale in
millimeters. The total score on the instrument is
computed by obtaining an average of the 16 scales.
The visual analogue scale format has multiple
advantages, including that it is easy to use, sensitive
to detecting small changes over time, and has similar
reliability and validity to more complex measures
[30]. The AFI can be easily administered and takes
approximately 5min to complete. A recognized
limitation of this format is that scoring can take
longer than other response formats.
Time period of assessment
The AFI measures an individual’s perceived effec-
tiveness in functioning at the time of administration,
i.e. the present time. An individual’s capacity to
function effectively is dynamic and fluctuates over
time based on the strength of attention. The goal of
the AFI is to measure a temporary state and not
underlying traits of the individual. Thus, the AFI is
particularly well suited for longitudinal assessment
of changes in perceived effectiveness of activities
requiring attention.
Positive and negative wording
The first 12 items are worded in a positive direction
(higher scores mean better performance) and the
last 4 items are reversed. This format reduces
possible confusion in responding as well as response
biases favoring either no difficulties or a great deal
of difficulties in activities supported by attention.
The AFI gives respondents new instructions before
reversing the direction of the questions in order to
cue respondents on a change in format. This
instrument has been well accepted by respondents,
and interitem correlations suggest that respondents
are able to accurately read and respond to the items
worded in both positive and negative directions.
Groups studied
The original 16-item AFI has been used in a variety of
populations, including both men and women ranging
in age from 22 to 84 years. It also has been translated
into Korean (Table 1). The internal consistency
coefficient (Cronbach’s a) of the 16-item AFI has
been consistently satisfactory, ranging from 0.76 to
0.94. (See Table 1 for the Cronbach’s a of individual
studies that have used the AFI.) The instrument has
been used along with objective neuropsychological
measures of cognitive function to describe both
changes in performance and perceived cognitive
function in various samples, indicating the need for
such a theory-based instrument. However, except for
the original nonparametric analysis of construct
validity in a small sample of women newly diagnosed
with breast cancer, no further work has been done to
confirm the psychometric properties of the AFI in
relation to validity. Thus, the objective of this study
was to test the reliability and validity of the
instrument with a larger sample of women newly
diagnosed with breast cancer.
Method
Participants
The sample consisted of 172 women, newly diag-
nosed with breast cancer recruited from a pool of
women, seeking breast cancer treatment at a
comprehensive cancer center. The participants
ranged in age from 27 to 86 with a mean age of
54 years. Participants were predominantly White
(90%) and relatively well educated with 82% having
had at least some college education. A majority were
post-menopausal (66%) by self-report and had a
clinical diagnosis of Stage I breast cancer (56%).
Individuals were excluded if they had a history of
psychiatric or neurological disorder, were taking
psychoactive medications, or had insufficient com-
mand of the English language. (See Table 2 for a
more detailed description of sample characteristics.)
Procedure
The University’s Institutional Review Board for
Medicine approved the study. Following written
consent, participants were assessed with a small
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battery of measures, including the AFI, during a
scheduled pre-treatment clinic visit in a quiet,
private room in the ambulatory care area. Testing
occurred about 22 days following diagnosis
by biopsy and about 17 days before primary
surgery for breast cancer. Participants were
recruited only after having been informed of
the clinical diagnosis and having decided on the
primary treatment plan.
Data analysis
Demographic and medical characteristics of the
sample were determined by descriptive statistics.
To determine conceptual redundancy, correlational
analysis was used to examine interitem relation-
ships. Construct validity of the AFI was examined
using principal component factor analysis with
varimax rotation; and this led to a revised
instrument. The reliability of the revised instru-
ment was determined by Cronbach’s a. Further
correlational analyses were conducted to establish
convergent and divergent validity of the revised
instrument with similar and contrasting measures,
respectively.
Results
The scores for each item on the AFI are described
in Table 3. The scores on the last four items were
reversed so that higher scores indicated better
perceived functioning. The scores on items ranged
from 0 to 100, suggesting good variance, with
participants’ responses ranging from poor to
satisfactory in perceived cognitive functioning
before primary treatment for breast cancer.
Analysis of interitem correlations
An examination of interitem correlations showed
that three items were highly correlated (rX0.80)
with other items. Further examination indicated
Table 2. Demographic and medical characteristic of sample
Characteristics Total sample (N 5 172)
N %
Education














Stage 0 15 8.8
Stage I 96 56.5
Stage II 56 32.9
Stages III and IV 3 1.8
aIncludes grade school, some high school, and high school diploma.
bIncludes some college, undergraduate degree, some graduate work, graduate
degrees, and other schooling.
cMissing data on one subject.
dMissing data on two subjects.
Table 3. Original AFI scale and item analysis
AFI scale (16-item) Item information
M SD Reliability Item M SD Rangea
65.51 18.03 0.94 Getting started on activities 62.40 25.24 9–100
Planning your daily activities 68.22 23.31 11–100
Following through on plans 66.56 24.76 10–100
Doing things that take time and effort 65.28 24.76 6–100
Making mind up about things 64.41 24.35 3–100
Finishing things you have started 68.59 22.28 6–100
Keeping mind on what you are doing 63.77 25.02 5–100
Remembering to do the things you started out to do 61.23 24.90 7–100
Keeping track of what you are saying and doing 62.25 25.17 3–100
Keeping mind on what others are saying 62.26 24.52 5-100
Keeping self from saying or doing things 73.02 21.82 11–100
Being patient with others 69.77 24.10 5–100
How hard you find it to concentrate on detailsb 61.19 27.33 0–100
How often you make mistakesb 65.74 24.66 0–100
Forgetting important thingsb 69.97 24.34 1–100
Getting easily annoyed/irritatedb 63.44 27.14 0–100
aPossible range of scores for scale is 0–100.
bData for reversed items transformed.
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that the three items, planning your daily activities,
finishing things you have started, and keeping track
of what you are saying and doing, were conceptually
redundant with other items and so were deleted
from the instrument to reduce inflation of the
internal consistency coefficient. This resulted in a
13-item instrument. A fourth item, getting easily
annoyed or irritated, was found to have low
correlations with other items (rp0.30) but was
deemed to be conceptually important, particularly
as an affective response to declines in attentional
functioning. Thus, in the following analysis of
construct validity, the instrument was examined
both with and without this item.
Construct validity of the AFI
Factor analysis, specifically exploratory principal
component analysis, was used to determine con-
struct validity and the best factor solution for the
reduced 13-item instrument. Findings indicated a
significant Bartlett’s test [w2 (78, N5 172)5
1581.94, p5o0.001], a Kaiser–Meyer–Olkin
(KMO) measure of 0.89, and item communalities
40.60. A second factor analysis of the 12-item
instrument (without the item ‘getting easily an-
noyed or irritated’) produced similar results with a
significant Bartlett’s test [w2 (66, N5 172)5
1439.35, p5o0.001], a KMO measure of 0.90,
and item communalities40.60. Thus, this item was
retained in the scale and the 13-item AFI was
accepted for further subscale analysis as detailed
below.
Factors for the 13-item AFI were evaluated on
both eigenvalues and the scree plot. Three factors
were extracted based on the following criteria: (1)
eigenvalues greater than 1.00, and (2) factor
loadings of X0.40. (Factor patterns are shown in
Table 4.) The factors were named Effective Action,
Attentional Lapses, and Interpersonal Effective-
ness. As shown in Table 4, three items are loaded
on more than one factor. Two items, remembering
to do all the things you started out to do and keeping
your mind on what others are saying, have a strong
conceptual link with Factor 1, Effective Action,
and thus were retained in this subscale. The third
item, getting easily annoyed or irritated, is concep-
tually consistent with Factor 3, Interpersonal
Effectiveness, and was retained in this factor.
In summary, factor analysis indicated that the
13-item scale containing three subscales reflected
theoretical congruence with the constructs of
directed attention and executive functioning.
Factor 1, Effective Action, contained 7 items
assessing an individual’s perceived effectiveness in
carrying out basic activities in daily living that
require focused attention. This factor integrated
items from the original subscales of perceptual
effectiveness and effective actions. Factor 2, Atten-
tional Lapses, contained 3 items measuring per-
ceived difficulties in directing attention in daily
tasks. Finally, Factor 3, Interpersonal Effective-
ness, contained 3 items reflecting perceived ability
to interact in a deliberate manner that depends on
attentional or inhibitory effort. The three factor
solution makes conceptual sense. The total var-
iance explained by these three factors was 74.69%.
(See Tables 5 and 6 for descriptive scores of
the revised AFI and the three subscales, and the
Appendix for a copy of the instrument.) The
revised 13-item AFI was further examined for
reliability and convergent and divergent forms of
validity, and the findings are presented below.
Reliability of the revised AFI
The internal consistency coefficient (Cronbach’s a)
for the revised 13-item scale was 0.92, indicating
satisfactory reliability. The revised AFI demon-
strated strong item-total correlations, indicating a
good ability to discriminate between high and low
scores [31] (Table 5). The reliabilities of the new
Table 4. Modified 13-item AFI factor loadings using principal component analysis with varimax rotation






Getting started on activities you intend to do 0.87
Following through on your plans 0.87
Doing things that take time and effort 0.83
Keeping your mind on what you are doing 0.73
Making your mind up about things 0.72
Remembering to do all the things you started out to do 0.65 0.47
Keeping your mind on what others are saying 0.56 0.52
How often you make mistakes on what you are doing 0.85
Forgetting to do important things 0.85
How hard you find it to concentrate on details 0.75
Being patient with others 0.88
Keeping self from saying or doing things 0.80
Getting easily annoyed or irritated 0.58 0.61
198 B. Cimprich et al.
Copyright r 2010 John Wiley & Sons, Ltd. Psycho-Oncology 20: 194–202 (2011)
DOI: 10.1002/pon
subscales are satisfactory and are described in
Table 6.
Convergent validity of the revised AFI
Convergent validity was tested by (1) assessing the
correlation between the total scores of the revised
AFI and the scores on the concentration item in the
Symptom Distress Scale (SDS) (developed by
McCorkle and Young [32]), which is widely used
in cancer populations, and (2) assessing the
correlation between the total scores on the revised
AFI and the total scores on the Cognitive Failures
Questionnaire (CFQ) [33]. Scores on the concen-
tration item in the SDS scale range from 1 (no
problem) to 5 (worst possible problem) at the
present time. The CFQ consists of 25 items that
measure participants’ perceived failures in percep-
tion, memory, and motor function, which are
deemed to be associated with attentional control.
The CFQ scale has a range from 0 (no reported
mistakes during the past few weeks) to 4 (made
mistakes very often during the past few weeks).
A significant negative correlation was found
between the revised AFI total scores and scores on
the concentration item (r50.58, po0.01), indi-
cating that higher overall effectiveness in perceived
attentional functioning was associated with less
difficulty concentrating. Similar results were
found when assessing the correlation between
the total scores of the revised AFI and the CFQ.
A significant negative correlation was found
between the revised AFI total scores and
scores on the CFQ (r50.60, po0.01). This
finding suggests that as the perceived attention
function scores improved, reported cognitive
failures decreased.
Divergent validity of the revised AFI
Divergent validity of the 13-item AFI was tested by
(1) assessing the correlation between total scores on
the revised AFI and total scores on the Confusion
subscale of the Profile of Moods States—Short
Form (POMS-SF) [34], and (2) assessing the
predictive validity of the AFI for self-ratings of
mental and physical fatigue using related items on
the SDS. The confusion subscale included the
following five items: confused, muddled, bewil-
dered, efficient, and forgetful. Each item was scored
from 0 (have not at all been feeling this way in the
past week) to 4 (have extremely been feeling
this way in the past week), with reverse coding of
the efficient item. As expected, a significant
negative correlation was found between the
AFI total scores and scores on the Confusion
subscale (r50.59, po0.01). This finding
suggests that as AFI scores increased (with better
perceived attentional function), feelings of confu-
sion decreased.
A multiple regression analysis indicated a
significant [F(3, 167)5 33.27, po.001] predictive
relationship between total AFI scores on the
Table 5. Descriptive analysis of the revised AFI
Revised AFI scale (13-item) Item information
M SD Reliability Item M SD ra Rangeb
65.31 17.95 0.92 Getting started on activities 62.40 25.24 0.66 9–100
Following through on plans 66.56 24.76 0.70 10–100
Doing things that take time and effort 65.28 24.76 0.69 6–100
Making mind up about things 64.41 24.35 0.72 3–100
Keeping mind on what you are doing 63.77 25.02 0.73 5–100
Remembering to do things you started out to do 61.23 24.90 0.77 7–100
Keeping mind on what others saying 62.26 24.52 0.74 5–100
Keeping self from saying or doing things 73.02 21.82 0.60 11–100
Being patient with others 69.77 24.10 0.62 5–100
How hard you find it to concentrate on detailsc 61.19 27.33 0.67 0–100
How often you make mistakesc 65.74 24.66 0.65 0–100
Forgetting important thingsc 69.97 24.34 0.65 0–100
Getting easily annoyed/irritatedc 63.44 27.14 0.47 1–100
aThe corrected item-total correlation.
bPossible range of scores for scale is 0–100.
cData for reversed items transformed.
Table 6. Mean, standard deviation, and internal reliabilities for
the three newly derived subscales





Factor 1: effective action
(7 items)
63.70 20.48 0.92
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revised instrument and scores on the SDS item of
mental fatigue. Specifically, increased AFI scores
(indicating better attentional function) were
associated with lower scores for mental tiredness.
At the same time, AFI scores were not significantly
related to scores on the SDS item of physical
fatigue, suggesting that scores on the revised
AFI cannot predict experience of physical
fatigue. Thus, the total score on the revised AFI
instrument seems to predict mental fatigue but
not physical fatigue, which suggests that the
instrument may be capable of discriminating
between mental or cognitive fatigue and physical
states of fatigue.
Possible covariates
Certain demographic characteristics should be
considered when assessing cognitive function.
Specifically, increased age, fewer years of educa-
tion, and the presence of chronic illnesses have
been associated with lower scores on objective
measures of cognitive functioning [6]. As such, the
relationships between perceived attentional func-
tion and age, education, and presence of chronic
health problems were examined. Age was found to
have a significant positive relationship with total
scores on the revised AFI (Pearson’s r5 0.21,
p5 0.01). Thus, younger women reported lower
attentional functioning and older women reported
higher attentional functioning. Interestingly,
although this finding is inconsistent with those
associated with objective measures of cognitive
functioning, it may suggest that younger women
react to small changes in the level of their
functioning, while older women may have adapted
to lower expectations of effectiveness in daily
functioning related to normal aging. Years of
education was not significantly correlated with
scores on the revised AFI (Pearson’s r50.01,
p5 0.94). Thus, years of education were not
associated with perceived cognitive functioning.
Finally, the sample was divided into two groups,
those reporting a stable chronic illness, such
as hypertension, heart disease, or diabetes
(n5 82), and those without (n5 89). No differences
were found in total revised AFI scores based on
presence or absence of a chronic illness (t50.02,
p5 0.98). In summary, although age, education,
and chronic illness are associated with scores on
objective performance measures of cognitive
function, only age was significantly related to
scores on the AFI.
This study examined the AFI in a sample of
women newly diagnosed with breast cancer.
Possible differences in responses based on gender
were not assessed. Although the original AFI has
been used with both men and women, continued
research is needed to examine possible response
differences between genders.
Discussion
The results of this study demonstrate the validity
and reliability of the AFI, a theoretically based
instrument designed to assess perceived effective-
ness in purposeful daily activities that rely on
basic cognitive processes. In particular, the AFI
assesses perceived changes in attention, working
memory, and higher-level executive functions,
including setting goals, planning and carrying
out tasks, and monitoring behavior to meet
intended goals. In addition, the AFI provides
assessment of perceived losses in the capacity to
direct attention.
The original 16-item instrument was revised
based on factor analysis to reduce unnecessary
redundancy and increase the precision of its
psychometric properties. The resulting 13-item
instrument has three distinct subscales that are
theoretically congruent with changes in attentional
functioning, namely effective action, attentional
lapses, and interpersonal effectiveness. While
use of the subscales may be appropriate at times,
from a theoretical point of view, the use of the total
score provides an overall index of the effectiveness
of the construct of attentional functioning.
Furthermore, the revised instrument showed good
internal consistency with theoretically congruent
findings on tests of convergent and divergent
validity.
Overall, the findings indicate that the AFI is a
valid and reliable measure for assessing the
perceived detrimental effects of cognitive dysfunc-
tion, particularly alterations in attention and
working memory on daily activities in chronic
and life-threatening illness, such as breast cancer.
To date, few measures have been available to assess
subjective perceptions of effectiveness in activities
of daily living that are supported by basic cognitive
functions. The original AFI has been used with
both healthy and ill populations to examine the
impact of perceived cognitive alterations on the
ability to carry out everyday activities. The new
revised AFI has demonstrated further usefulness
for research studies examining cognitive dysfunc-
tion, particularly problems of attention and
working memory in persons with chronic illnesses,
such as breast cancer. In particular, the instrument
can be useful in future research to better under-
stand how patient-reported functional outcomes
and perceived effectiveness in everyday activities
correlate to actual performance on neuro-
psychological tests. Such information is currently
lacking and is especially needed to support
development of targeted interventions to improve
cognitive functioning in individuals with
cancer. Last, the findings provide the needed
foundation for further testing of the validity and
reliability of the AFI in various healthy and ill
populations.
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Appendix
I. At this time, how well do you feel you are functioning in each of the areas below?
Place a mark through the line at whatever point best describes how you are doing in each area at present.
II. At this time, how would you rate yourself on:
10.  How hard you find it to concentrate on details. 
         Not at all                         A great deal
   
11.  How often you make mistakes on what you are doing. 
         Not at all             A great deal    
   
12.  Forgetting to do important things. 
         Not at all             A great deal    
   
13.  Getting
Lines are not printed to 100 mm scale.Note :
 easily annoyed or irritated. 
        Not at all            A great deal    
    
1. Getting started on activities (tasks, jobs) you intend to do. 
      Not at all           Extremely well
      
2. Following through on your plans. 
      Not at all             Extremely well
   
3. Doing things that take time and effort. 
      Not at all             Extremely well
  
4. Making your mind up about things.  
   Not at all             Extremely well
   
5. Keeping your mind on what you are doing. 
      Not at all           Extremely well
   
6. Remembering to do all the things you started out to do. 
      Not at all              Extremely well
    
7.  Keeping your mind on what others are saying. 
     Not at all                     Extremely well
   
8.  Keeping yourself from saying or doing things you did not want to say or do. 
         Not at all            Extremely well 
    
9.  Being patient with others. 
    Not at all                    Extremely well
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